Hospital
Upper Connecticut Valley Hospital Association
Upper Connecticut Valley Hospital Association was paid $1.12M by Medicaid between Jan 2018 and Nov 2024, across 42 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 34% of everything it billed.
33Billing provider infoUPPER CONNECTICUT VALLEY HOSPITAL ASSOCIATION
COLEBROOK, NH 03576
COLEBROOK, NH 03576
33aNPI1861489437assigned 09/29/2005
33bProvider typeCritical Access Hospital
28Total paid$1.12M
24GClaims34,441
24DCodes billed42
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in New Hampshire
Rank by total paid#8 of 9
Median peer was paid$5.24M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,347 | $113K | |
| 2019 | 6,427 | $149K | |
| 2020 | 6,484 | $174K | |
| 2021 | 7,820 | $268K | |
| 2022 | 6,337 | $279K | |
| 2023 | 1,299 | $73K | |
| 2024incomplete | 727 | $68K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 34% | 3,475 | 2,601 | $382K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 3,700 | 2,611 | $306K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 1,226 | 652 | $120K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.1% | 783 | 633 | $57K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.2% | 736 | 589 | $47K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.1% | 1,665 | 1,292 | $34K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 657 | 150 | $28K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 933 | 514 | $20K |
| 80053 | Comprehensive metabolic panel | 1.6% | 3,884 | 2,747 | $17K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 257 | 160 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 4,420 | 2,892 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 435 | 172 | $11K |
30 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 210 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,017 | $9K |
| 80061 | Lipid panel | <1% | 815 | $9K |
| 99285 | Emergency room visit (most serious) | <1% | 72 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 148 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 96 | $5K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 50 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 616 | $5K |
| 87631 | <1% | 36 | $3K | |
| 83735 | <1% | 1,157 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 114 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 45 | $2K |
| 81001 | <1% | 1,122 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,192 | $1K |
| 84484 | <1% | 437 | $908.79 | |
| 71045 | Radiologic examination, chest; single view | <1% | 14 | $833.96 |
| 87276 | <1% | 91 | $812.13 | |
| 87275 | <1% | 91 | $631.64 | |
| J3490 | Unclassified drugs | <1% | 562 | $619.76 |
| 84439 | <1% | 85 | $547.97 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 20 | $345.05 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $255.51 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 60 | $214.72 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 34 | $129.35 |
| 82044 | <1% | 31 | $118.80 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 64 | $112.86 |
| 83605 | <1% | 26 | $81.92 | |
| 83690 | <1% | 15 | $56.24 | |
| 86140 | <1% | 16 | $44.49 | |
| 85610 | <1% | 21 | $19.83 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRIZZELL, PAMELA (CONTROLLER)